Emerald Medical Application

Company Overview

Snapshot

Founded in February 2010 by Lior Wayn, Emerald Medical Application operates with 1–10 employees. The company has raised $1.55M across two funding rounds. In May 2016, the company announced an equity purchase agreement with Kodiak Capital Group, LLC.

Business overview

Emerald Medical Application develops technology for the early detection of skin cancer and other anomalies, leveraging military image processing and big-data analytics to enhance medical image analysis. Its core product, DermaCompare, is a Class 1, FDA-approved, HIPAA-compliant platform that enables physicians to monitor changes in patients' skin health. Available as a mobile application on iOS and Android, DermaCompare allows patients to capture and transmit Total Body Photography images for dermatological evaluation. The platform serves the healthcare industry, operating within the Health Tech & Life Sciences sector, with a focus on digital medical diagnostics, artificial intelligence, machine learning, and cloud-based software solutions.

Strategic signal

In November 2016, Emerald Medical Application's DermaCompare technology was selected as one of four startup technology winners in Merck's Health Innovation Technology Scouts (HITS) Program. This recognition from a major pharmaceutical company like Merck signals strong industry validation for Emerald Medical Application's innovative approach to skin cancer detection and highlights its potential for strategic partnerships and market adoption within the health tech landscape.

Company Intelligence Q&A

What is Emerald Medical Application's primary product?

Emerald Medical Application's primary product is DermaCompare, a Class 1, FDA-approved, HIPAA-compliant skin cancer screening platform that utilizes military image processing and big-data analytics for early detection and monitoring of skin anomalies.

When was Emerald Medical Application founded?

Emerald Medical Application was founded in February 2010.

Which investor participated in a funding round for Emerald Medical Application?

In May 2016, Kodiak Capital Group, LLC participated in an equity purchase agreement with Emerald Medical Application.

What recognition did Emerald Medical Application receive in November 2016?

In November 2016, Emerald Medical Application's DermaCompare technology was chosen as one of four startup technology winners in Merck's Health Innovation Technology Scouts (HITS) Program.

What award did Emerald Medical Application receive at Viva Technology Paris?

Emerald Medical Application was awarded first prize out of 3,500 tech companies in the Publicis Groupe 90 initiative at the inaugural edition of Viva Technology Paris in July 2016.